News PM Society Awards - new category for 2023 PM Society Awards 17th March 2023 | JW Marriott Grosvenor House
Articles Creativity in healthcare comms: polevaulting over everyday o... We need creative ways to engage people in healthcare
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
